Nutrition

Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023

Company reaches major strategic inflection point, with operations and revenue ramp-up underwayInaugural 2026 guidance introduced; target to achieve:More than $180...

VALBIOTIS SA: Valbiotis Presents the Full Results of the Phase II/III REVERSE-IT Study: Impressive Efficacy of TOTUM•63 Against Prediabetes and the Early Stages of Type 2 Diabetes, a First for a Non-drug Active Substance

Pressure BioSciences’ BaroFold Technology Achieves Pivotal Equipment Sale and Begins Scale-up in Service to Leading Global Contract Devt. & Mfg. Organization

Patented BaroFold Platform is Critical Enabler for Biopharma Manufacturing and Quality Assurance;Company Believes Future BaroFold Equipment and Recurring Utilization/Support FeesShould...

BioAdaptives, Inc. Announces the Spin-off Its LiveStock Impact Division as a Wholly Owned Subsidiary, LiveStock Impact, Inc., Focusing on New Product Development and Global Marketing of Animal Health Supplement Products and Botanical Drugs

Elicio Therapeutics Receives $2.6 Million Grant from the Gastro-Intestinal (GI) Research Foundation to Fund Research for Two Therapeutic Cancer Vaccines

Funds will advance research into ELI-007, a mutant BRAF-peptide vaccine, and ELI-008, a p53 hotspot mutation-peptide vaccine, with the aim...

error: Content is protected !!